Subscribe To

Price Alert Latest News Economic Calendar News

OGI / OrganiGram Holdings Inc. (OGI) Q4 2022 Earnings Call Transcript

OrganiGram Holdings Inc. (NASDAQ:OGI ) Q4 2022 Results Conference Call November 29, 2022 8:00 AM ET Company Participants Craig MacPhail - Group Director, NATIONAL Capital Markets Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Tamy Chen - BMO Capital Markets Ty Collin - Eight Capital Aaron Grey - Alliance Global Partners Andrew Partheniou - Stifel Matt Bottomley - Canaccord Genuity Michael Freeman - Raymond James Frederico Gomes - ATB Operator Good morning. My name is Rob, and I will be your conference operator today. Read More

Demo Live Account See Partner Details

Content Topics

Organigram

Holdings

Inc

OGI

2022

Earnings

Call

Transcript

Stock

Posted: Nov 29 2022, 12:50

Author Name: Seeking Alpha

OGI News

By Seeking Alpha
September 30, 2023

Organigram Holdings: Earnings Growth Set To Continue

Growing brands and strategic positioning show OGI's future potential. Having overcome recent challenges, OGI is positioned to thrive in the changing c

By Seeking Alpha
July 17, 2023

Organigram Is Still My Favorite Cannabis Stock

I have followed Organigram closely since it went public in 2014. The Q3 report on 7/13 was a disaster on two fronts. I find the valuation currently to

By MarijuanaStocks
July 14, 2023

3 Top Marijuana Stocks Of 2023 To Watch Right Now

Marijuana stock investors are always on the lookout for their next opportunity. In the cannabis industry that can be at any time with how young and vo

By Seeking Alpha
July 14, 2023

Organigram Holdings Inc. (OGI) Q3 2023 Earnings Call Transcript

Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2023 Earnings Conference Call July 14, 2023 8:00 AM ET Company Participants Max Schwartz - Director, IR Been

By Business Wire
July 7, 2023

Organigram to Report Third Quarter Fiscal 2023 Results on July 13, 2023

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “

By Zacks Investment Research
June 27, 2023

Organigram (OGI) Grows in Cannabis Space With SHRED X Heavies

Organigram's (OGI) SHRED X Heavies is not only the first infused pre-roll in the SHRED product portfolio but also joins a lineup of value-driven, conv

By MarijuanaStocks
June 20, 2023

The Global Influence On Marijuana Stocks And The Cannabis Industry

International markets are playing a significant role in shaping the future of the cannabis industry. Countries such as Canada, Uruguay, and several Eu

By MarijuanaStocks
May 18, 2023

Canadian Cannabis Stocks Under $2 To Watch Now

Canadian Pot Stocks To Watch In May The post Canadian Cannabis Stocks Under $2 To Watch Now appeared first on Marijuana Stocks | Cannabis Investments

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.